Marshall Wace, LLP Enochian Biosciences Inc Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 34,261 shares of ENOB stock, worth $157,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,261Holding current value
$157,600% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ENOB
# of Institutions
43Shares Held
7.25MCall Options Held
16KPut Options Held
12.5K-
Vanguard Group Inc Valley Forge, PA3.92MShares$18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$2.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY375KShares$1.73 Million0.0% of portfolio
-
Black Rock Inc. New York, NY314KShares$1.45 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY306KShares$1.41 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...